期刊
BLOOD
卷 127, 期 16, 页码 1987-1997出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2015-07-657056
关键词
-
类别
资金
- Giovanni Armenise-Harvard Foundation
- Italian Association for Cancer Research Special Program Molecular Clinical Oncology [9965, 12769]
- CLL Global Research Foundation
- Career Development Award
Hypoxia-inducible transcription factors (HIFs) regulate a wide array of adaptive responses to hypoxia and are often activated in solid tumors and hematologic malignancies due to intratumoral hypoxia and emerging new layers of regulation. We found that in chronic lymphocytic leukemia (CLL), HIF-1 alpha is a novel regulator of the interaction of CLL cells with protective leukemia microenvironments and, in turn, is regulated by this interaction in a positive feedback loop that promotes leukemia survival and propagation. Through unbiased microarray analysis, we found that in CLL cells, HIF-1 alpha regulates the expression of important chemokine receptors and cell adhesion molecules that control the interaction of leukemic cells with bone marrow and spleen microenvironments. Inactivation of HIF-1 alpha impairs chemotaxis and cell adhesion to stroma, reduces bone marrow and spleen colonization in xenograft and allograft CLL mouse models, and prolongs survival in mice. Of interest, we found that in CLL cells, HIF-1 alpha is transcriptionally regulated after coculture with stromal cells. Furthermore, HIF-1 alpha messenger RNA levels vary significantly within CLL patients and correlate with the expression of HIF-1 alpha target genes, including CXCR4, thus further emphasizing the relevance of HIF-1 alpha expression to CLL pathogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据